Home

HISTORY

CONTACT US

NEWS AND PR

MEET DR. OBAGI

PRIVACY POLICY

TERMS AND CONDITIONS

Investor Relations
Investor Relations
Corporate Governance
Event Calendar
Stock Information
News Releases
SEC Filings
Annual Reports
Proxy Materials
Analysts
Earnings Estimates
Investor FAQ
E-mail Alerts
Information Request
Contact Information


For PatientsFor PhysiciansFor Skin Care SpecialistsAbout Obagi System



Investor Overview



Webcast ImageWebcast
Q3 2009 OBAGI MEDICAL PRODUCTS INC Earnings Conference Call (Replay)
11/05/09 at 4:30 p.m. ET
Corporate Profile
We are a specialty pharmaceutical company focused on the aesthetic and therapeutic skin health markets. We develop and commercialize prescription-based, topical skin health systems that enable physicians to treat a range of skin conditions, including pre-mature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne and soft tissue deficits, such as fine lines and wrinkles. Our products are designed to improve the underlying health of patients’ skin... More >>
Stock Quote
OMPI (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$10.76
Change (%) Stock is Up 0.02 (0.19%)
Volume46,231
Data as of 11/20/09 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
11/05/09Obagi Medical Products Reports Third Quarter 2009 EarningsPrinter Friendly Version
10/19/09Obagi Medical Products to Report Third Quarter 2009 Financial Results and Host a Conference Call on November 5, 2009Printer Friendly Version
09/18/09Obagi Medical Products to Present at The UBS Life Science ConferencePrinter Friendly Version
08/06/09Obagi Medical Products Reports Second Quarter 2009 Financial ResultsPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Featured Report
Download Documentation 2008 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Obagi Medical Products, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.